碎石设备市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球碎石设备市场规模达 16 亿美元，预计 2025 年至 2034 年的复合年增长率将达到 6.3%。碎石设备已成为现代泌尿外科的重要工具，为分解肾臟、膀胱、胰臟和胆管中形成的结石提供了可靠的非侵入性解决方案。这些设备利用衝击波和超音波等先进的能量源将结石碎成更小的碎片，从而实现自然排出或简单去除。由于肥胖率上升、代谢紊乱和不良的饮食习惯，越来越多的人面临肾结石和胆结石等泌尿系统疾病，对有效的结石管理解决方案的需求正在迅速增长。

患者对微创治疗认识的不断提高，加上碎石设备的技术进步，为市场扩张创造了有利条件。全球人口老化，由于糖尿病和高血压等合併症，更容易形成结石，预计未来十年对这些设备的需求也将持续增长。医疗保健提供者越来越多地采用碎石技术，可提供精确、有针对性的治疗，减少住院时间，从而带来更好的患者治疗效果。随着医院和专科诊所寻求最大限度地降低手术风险并优化患者的康復期，向门诊护理和非侵入性治疗的持续转变正在进一步推动市场向前发展。

市场主要分为体内碎石设备和体外震波碎石设备，两者均可满足各种临床需求。 ESWL 设备在 2024 年创造了 8.418 亿美元的产值，预计 2025 年至 2034 年的复合年增长率为 6.2%。由于这些设备无需手术切口即可从外部打碎结石，因此仍受到医疗保健提供者的高度青睐。 ESWL 手术的非侵入性降低了感染和併发症的风险，有助于患者更快康復，并提高了医院和泌尿科中心对 ESWL 手术的接受度。 ESWL 的吸引力在于它能够利用先进的成像技术提供高精度结石定位，最大限度地减少对周围组织的损伤。

碎石设备用于治疗各种类型的结石，包括位于肾臟、输尿管、胰臟和胆管的结石，其中肾结石在 2024 年占据 43.1% 的市场份额。预计到 2034 年，这一细分市场将达到 13 亿美元，这主要是由于与缺水、不健康饮食和久坐不动的生活方式有关的肾结石病例日益增加。除了饮食和生活方式的影响外，遗传倾向和可能导致结石形成的药物的使用增加也增加了全球的病例数。

预计到 2034 年，仅美国碎石设备市场就将创造 11 亿美元的产值，这得益于将卓越疗效与患者舒适度相结合的下一代碎石系统的采用。便携式、紧凑型碎石设备的引入，可以快速设置和治疗，再加上即时成像引导的进步，大大提高了门诊和流动环境中执行的程序的效率。随着美国医疗保健提供者优先考虑微创解决方案，对碎石设备的需求持续攀升，反映出以患者为中心的护理和改善临床结果的更广泛趋势。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 泌尿系统结石盛行率不断上升
    • 碎石设备的技术进步
    • 老年人口不断增加
    • 大众对肾结石的认识提高
  • 产业陷阱与挑战
    • 碎石术相关併发症
    • 去除结石的替代治疗方法
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按设备类型，2021 年至 2034 年

• 主要趋势
• 体外震波碎石装置
• 体内碎石装置
  • 雷射碎石装置
  • 电液碎石装置
  • 超音波碎石装置
  • 机械式碎石装置

第六章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 肾结石
• 输尿管结石
• 胰臟结石
• 胆管结石

第七章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用途

第八章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第九章：公司简介

• Becton, Dickinson and Company
• Boston Scientific
• Cook Medical
• DirexGroup
• Dornier MedTech
• EDAP TMS
• ELMED Medical Systems
• EMS
• Inceler Medikal
• Medispec
• MTS Medical
• Olympus
• Richard Wolf
• Siemens Healthineers
• STORZ MEDICAL

The Global Lithotripsy Devices Market generated USD 1.6 billion in 2024 and is poised to grow at a CAGR of 6.3% from 2025 to 2034. Lithotripsy devices have emerged as vital tools in modern urology, offering a reliable, non-invasive solution to break down stones that form in the kidneys, bladder, pancreas, and bile ducts. These devices utilize advanced energy sources such as shock waves and ultrasound to fragment stones into smaller pieces, enabling natural expulsion or simple removal. As more people face urological conditions like kidney stones and gallstones, primarily due to rising obesity rates, metabolic disorders, and poor dietary habits, the demand for efficient stone management solutions is rapidly growing.

Increasing awareness among patients about minimally invasive treatments, coupled with technological advancements in lithotripsy devices, is creating favorable conditions for market expansion. The aging global population, which is more susceptible to stone formation due to comorbidities like diabetes and hypertension, is also expected to drive consistent demand for these devices over the next decade. Healthcare providers are increasingly adopting lithotripsy technologies that offer precise, targeted treatment with reduced hospitalization time, leading to better patient outcomes. The ongoing shift toward outpatient care and non-invasive therapies is further propelling the market forward as hospitals and specialty clinics seek to minimize procedural risks and optimize recovery periods for patients.

The market is primarily segmented into intracorporeal lithotripsy devices and extracorporeal shock wave lithotripsy devices, both of which cater to various clinical needs. ESWL devices generated USD 841.8 million in 2024 and are projected to grow at a CAGR of 6.2% from 2025 to 2034. These devices remain highly preferred among healthcare providers due to their ability to break stones externally without surgical incisions. The non-invasive nature of ESWL procedures reduces the risk of infections and complications, supporting faster patient recovery and increasing their acceptance across hospitals and urology centers. ESWL's appeal lies in its ability to provide high-precision stone targeting using advanced imaging technologies, minimizing damage to surrounding tissues.

Lithotripsy devices are used to treat various types of stones, including those located in the kidneys, ureters, pancreas, and bile ducts, with kidney stones accounting for a 43.1% market share in 2024. This segment is projected to reach USD 1.3 billion by 2034, driven by the growing prevalence of kidney stone cases linked to poor hydration, unhealthy diets, and sedentary lifestyles. In addition to dietary and lifestyle influences, genetic predisposition and the increased use of medications that may lead to stone formation are adding to the caseload worldwide.

The U.S. Lithotripsy Devices Market alone is expected to generate USD 1.1 billion by 2034, fueled by the adoption of next-generation lithotripsy systems that combine superior efficacy with patient comfort. The introduction of portable and compact lithotripsy devices that allow for quick setup and treatment, coupled with advancements in real-time imaging guidance, has significantly enhanced the efficiency of procedures performed in outpatient and ambulatory settings. As healthcare providers in the U.S. prioritize minimally invasive solutions, the demand for lithotripsy devices continues to climb, reflecting a broader trend toward patient-centric care and improved clinical outcomes.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of urolithiasis
    • 3.2.1.2 Technological advancements in lithotripsy devices
    • 3.2.1.3 Growing geriatric population
    • 3.2.1.4 Rise in public awareness about kidney stones
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Complications associated with lithotripsy
    • 3.2.2.2 Availability of alternative treatments for stone removal
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Extracorporeal shock wave lithotripsy devices
• 5.3 Intracorporeal lithotripsy devices
  • 5.3.1 Laser lithotripsy devices
  • 5.3.2 Electrohydraulic lithotripsy devices
  • 5.3.3 Ultrasonic lithotripsy devices
  • 5.3.4 Mechanical lithotripsy devices

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Kidney stones
• 6.3 Ureteral stones
• 6.4 Pancreatic stones
• 6.5 Bile duct stones

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Becton, Dickinson and Company
• 9.2 Boston Scientific
• 9.3 Cook Medical
• 9.4 DirexGroup
• 9.5 Dornier MedTech
• 9.6 EDAP TMS
• 9.7 ELMED Medical Systems
• 9.8 EMS
• 9.9 Inceler Medikal
• 9.10 Medispec
• 9.11 MTS Medical
• 9.12 Olympus
• 9.13 Richard Wolf
• 9.14 Siemens Healthineers
• 9.15 STORZ MEDICAL